Congressional Stock Trades & Disclosures
Ron Wyden is a U.S. Senator, a Democrat representing OR. As of July 2025, Bullish Whales has tracked 312 disclosed stock trades across 64 companies, representing $13.7M in disclosed transaction value, each filed publicly under the STOCK Act.
About Wyden's congressional trading
Wyden's disclosed activity shows a buy-leaning pattern, with 250 purchases and 62 sales (a buy-to-sell ratio of 4.03). Wyden has traded AAPL, NVDA, and AMZN most frequently among disclosed positions.
On the Bullish Whales Score, which ranks members of Congress by how worth-following their disclosed buys have been relative to peers, Wyden rates 70 out of 100, a Solid reading. The score weights a member's realized track record (80%) and conviction in repeat positions (20%); it is a descriptive research signal drawn from public filings, not investment advice.
Wyden's most recent disclosed trade was a sale of Pfizer Inc (PFE) from June 2025. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 PFEPfizer Inc | Sell | $1,001 - $15,000 | 03 JUN 2025 | $21.82 | +16.11% |
| PFEPfizer Inc | Sell | $1,001 - $15,000 | 03 JUN 2025 | $21.82 | +16.11% |
 LLYEli Lilly and Company | Sell | $50,001 - $100,000 | 10 FEB 2025 | $859.53 | +25.51% |
 IRBTiRobot Corporation | Sell | $1,001 - $15,000 | 06 FEB 2025 | N/A | — |
 SOLVSolventum Corp. | Sell | $1,001 - $15,000 | 06 FEB 2025 | $74.78 | +4.79% |
| LLYEli Lilly and Company | Buy | $50,001 - $100,000 | 22 JAN 2025 | $745.87 | +44.63% |
 UPSUnited Parcel Service Inc | Sell | $100,001 - $250,000 | 27 MAR 2024 | $128.98 | -15.75% |
 NFLXNetflix Inc | Sell | $50,001 - $100,000 | 11 NOV 2022 | $29.01 | +180.98% |
 DISWalt Disney Company | Sell | $50,001 - $100,000 | 11 NOV 2022 | $92.82 | +7.07% |
| IRBTiRobot Corporation | Sell | $15,001 - $50,000 | 11 NOV 2022 | N/A | — |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Ron Wyden congressional trading FAQ
Can Ron Wyden legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles Ron Wyden's disclosures so the public can review them.
Where does Bullish Whales get Ron Wyden's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Ron Wyden's stock trades?
Bullish Whales tracks every stock trade Ron Wyden discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Ron Wyden disclosed?
Bullish Whales has tracked 312 disclosed trades by Ron Wyden across 64 companies.
Which stocks does Ron Wyden trade most?
Ron Wyden's most frequently disclosed positions include AAPL, NVDA, AMZN, DIS, and MSFT. The full list of companies and individual filings is shown on this page.
What was Ron Wyden's most recent stock trade?
Ron Wyden most recently sold Pfizer Inc (PFE) in June 2025, according to public STOCK Act filings tracked by Bullish Whales.
What is Ron Wyden's Bullish Whales Score?
Ron Wyden has a Bullish Whales Score of 70 out of 100 (Solid). The score ranks members by how worth-following their disclosed buys have been, weighting realized track record (80%) and conviction (20%). It is a descriptive research signal, not investment advice.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.